At the Statesir Cancer Center at CentraState, the ability to identify and take advantage of what might make each patient’s cancer unique often facilitates better outcomes with fewer side effects.
Whereas past options were somewhat limited and acted on the entire body, molecular and genetic testing can now be used to pinpoint targeted therapies for cancer treatment based on an individual’s genetic makeup and cancer type.
For some cancers that develop slowly, or in circumstances where a patient’s age and medical history play a role, the strategy of active surveillance or watchful waiting may be employed. Active surveillance means delaying a course of treatment, while your physician monitors and tracks any changes your cancer may be making.
Of course, any technology is only as good as the experts that use it. Our cancer specialists are leaders in their respective fields and passionate about the medicine they practice. Depending on a variety of factors, including type and stage of cancer, there are a variety of treatment options available.